# EDGAR Filing Document

**Accession Number:** 0001603454
**File Stem:** 0001641172-25-013605
**Filing Date:** 2025-6
**Character Count:** 16426
**Document Hash:** 42a57304ca0a7287cdca582ae35bd140
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-013605.hdr.sgml**: 20250604

**ACCESSION NUMBER**: 0001641172-25-013605

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20250604

**DATE AS OF CHANGE**: 20250604

**EFFECTIVENESS DATE**: 20250604

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Celcuity Inc.
- **CENTRAL INDEX KEY:** 0001603454
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-287766
- **FILM NUMBER:** 251023135

**BUSINESS ADDRESS:**
- **STREET 1:** 16305 36TH AVENUE N
- **STREET 2:** SUITE 100
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55446
- **BUSINESS PHONE:** 763-392-0767

**MAIL ADDRESS:**
- **STREET 1:** 16305 36TH AVENUE N
- **STREET 2:** SUITE 100
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55446

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Celcuity LLC
- **DATE OF NAME CHANGE:** 20140324

**As filed with the Securities and Exchange Commission on June 4, 2025**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

**Under the Securities Act of 1933**

**CELCUITY INC.**

**(Exact Name of Registrant as Specified in its Charter)**

---

| | |
|:---|:---|
| **Delaware** | **82-2863566** |
| **(State or Other Jurisdiction of**<br> **Incorporation or Organization)** | **(I.R.S. Employer**<br> **Identification Number)** |

---

**16305 36th Avenue North, Suite 100**

**Minneapolis, Minnesota 55446**

**(Address of Principal Executive Offices and Zip Code)**

**Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan**

**Celcuity Inc. 2017 Employee Stock Purchase Plan**

**(Full Titles of the Plans)**

**Brian F. Sullivan**

**Chief Executive Officer**

**16305 36th Avenue North, Suite 100**

**Minneapolis, MN 55446**

**(763) 392-0767**

**(Name, Address and Telephone Number, Including Area Code, of Agent for Service)**

***Copies to:***

**Jonathan R. Zimmerman** **Griffin D. Foster**

**Faegre Drinker Biddle & Reath LLP**

**2200 Wells Fargo Center** **90 South Seventh Street**

**Minneapolis, MN 55402**

**(612) 766-7000**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**STATEMENT OF INCORPORATION BY REFERENCE**

The purpose of this Registration Statement is to register (i) 3,371,432 additional shares of the registrant's common stock, par value $0.001 per share (the "Common Stock"), reserved for issuance under the registrant's Amended and Restated 2017 Stock Incentive Plan, and (ii) 185,716 additional shares of Common Stock reserved for issuance under the registrant's 2017 Employee Stock Purchase Plan. This Registration Statement is submitted in accordance with General Instruction E to Form S-8 regarding registration of additional securities, and pursuant to such instruction, the contents of the Registration Statements on Form S-8 (File Nos. 333-221117, 333-238787, 333-253940, 333-256500, 333-265328, 333-270238, 333-271976, and 333-279556) are incorporated herein by reference, except for Item 8, Exhibits.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 8. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 5.1 | [<u>Opinion of Faegre Drinker Biddle & Reath LLP</u>](ex5-1.htm) |
| 23.1 | [<u>Consent of Boulay PLLP</u>](ex23-1.htm) |
| 23.2 | [<u>Consent of Faegre Drinker Biddle & Reath LLP (included in Exhibit 5.1)</u>](ex5-1.htm) |
| 24.1 | [Power of Attorney (included on signature page hereof)](#aw_002) |
| 99.1 | [Celcuity Inc. 2017 Employee Stock Purchase Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant's Registration Statement on Form S-1/A filed on September 12, 2017)](https://www.sec.gov/Archives/edgar/data/1603454/000157104917007846/t1702519_ex10-1.htm) |
| 99.2 | [Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Registrant's Current Report on Form 8-K filed on May 16, 2025)](https://www.sec.gov/Archives/edgar/data/1603454/000164117225011273/ex10-1.htm) |
| 107 | [<u>Filing Fee Table</u>](ex107.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, as amended (the "Securities Act"), the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Minneapolis, State of Minnesota, on June 4, 2025.

---

| | |
|:---|:---|
| **CELCUITY INC.** | **CELCUITY INC.** |
| By: | */s/ Brian F. Sullivan* |
|  | Brian F. Sullivan<br> *Chief Executive Officer* |

---

**POWER OF ATTORNEY**

The undersigned directors and officers of Celcuity Inc. hereby severally constitute and appoint Brian F. Sullivan and Vicky Hahne as attorneys-in-fact for the undersigned, each of them singly, with full and several power of substitution for, and in the name, place and stead of, the undersigned, to sign and file with the Securities and Exchange Commission under the Securities Act, any and all amendments (including post-effective amendments) and exhibits to this registration statement on Form S-8 (or any other registration statement for the same offering that is to be effective upon filing pursuant to Rule 462(b) under the Securities Act) and any and all applications and other documents to be filed with the Securities and Exchange Commission pertaining to the registration of the securities covered hereby, with full power and authority to do and perform any and all acts and things whatsoever requisite and necessary or desirable, hereby ratifying and confirming all that said attorneys-in-fact, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/ Brian F. Sullivan* | Chief Executive Officer (Principal Executive Officer), | June 4, 2025 |
| Brian F. Sullivan | Director and Chairman |  |
| */s/ Vicky Hahne* | Chief Financial Officer (Principal Financial and | June 4, 2025 |
| Vicky Hahne | Accounting Officer) |  |
| */s/ Lance G. Laing* | Chief Science Officer, Vice President and Secretary, | June 4, 2025 |
| Lance G. Laing | and Director |  |
| */s/ Richard E. Buller* | Director | June 4, 2025 |
| Richard E. Buller |  |  |
| */s/ David F. Dalvey* | Director | June 4, 2025 |
| David F. Dalvey |  |  |
| */s/ Leo T. Furcht* | Director | June 4, 2025 |
| Leo T. Furcht |  |  |
| */s/ Polly A. Murphy* | Director | June 4, 2025 |
| Polly A. Murphy |  |  |
| */s/ Richard J. Nigon* | Director | June 4, 2025 |
| Richard J. Nigon |  |  |

---

## Exhibit 5.1

**Exhibit 5.1**

![](ex5-1_001.jpg)

**Faegre Drinker Biddle & Reath LLP**

2200 Wells Fargo Center

90 South Seventh Street

Minneapolis, Minnesota 55402

+1 612 766 7000 main

June 4, 2025

Celcuity Inc.

16305 36<sup>th</sup> Avenue North, Suite 100

Minneapolis, Minnesota 55446

Re: <u>Registration Statement on Form S-8</u>

Ladies and Gentlemen:

We have acted as counsel to Celcuity Inc., a Delaware corporation (the "<u>Company</u>"), in connection with the preparation and filing with the Securities and Exchange Commission (the "<u>Commission</u>") of the Company's Registration Statement on Form S-8 (the "<u>Registration Statement</u>") under the Securities Act of 1933, as amended (the "<u>Act</u>"), registering the offer and sale of (i) up to 3,371,432 additional shares (the "<u>2017 Plan Shares</u>") of the Company's common stock, $0.001 par value per share (the "<u>Common Stock</u>"), issuable pursuant to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan (the "<u>2017 Plan</u>"), and (ii) up to 185,716 additional shares of Common Stock (the "<u>ESPP Shares</u>" and, together with the 2017 Plan Shares, the "<u>Shares</u>") issuable pursuant to the Celcuity Inc. 2017 Employee Stock Purchase Plan (the "<u>ESPP</u>" and, together with the 2017 Plan, the "<u>Plans</u>").

For purposes of this opinion letter, we have examined the Plans, the Registration Statement, the Company's Certificate of Incorporation, as amended and currently in effect, the Company's Bylaws, as currently in effect, and the resolutions of the Company's Board of Directors authorizing the issuance of the Shares. We have also examined a certificate of the Assistant Secretary of the Company dated the date hereof (the "<u>Certificate</u>") and originals, or copies certified or otherwise authenticated to our satisfaction, of such corporate and other records, agreements, instruments, certificates of public officials and documents as we have deemed necessary as a basis for the opinions hereinafter expressed and have made such examination of statutes as we have deemed relevant and necessary in connection with the opinions hereinafter expressed. As to facts material to this opinion letter, we have relied upon certificates, statements or representations of public officials, of officers and representatives of the Company (including the Certificate) and of others, without any independent verification thereof.

In our examination, we have assumed, without independent verification or investigation: (i) the legal capacity of all natural persons; (ii) the genuineness of all signatures, including electronic signatures; (iii) the authenticity of all documents submitted to us as originals; (iv) the conformity to original documents of all documents submitted to us as certified, conformed, photostatic or facsimile copies; (v) the authenticity of the originals of such latter documents; (vi) the truth, accuracy and completeness of the information, representations and warranties contained in the agreements, documents, instruments, certificates and records we have reviewed; and (vii) the absence of any undisclosed modifications to the agreements and instruments reviewed by us.

Based upon such examination and review, and subject to the foregoing and the other qualifications, assumptions and limitations set forth herein, we are of the opinion that all necessary corporate action on the part of the Company has been taken to authorize the issuance and sale of the 2017 Plan Shares to be issued in accordance with the 2017 Plan and the ESPP Shares to be issued in accordance with the ESPP and that, when (a) the 2017 Plan Shares have been issued and sold as contemplated in the Registration Statement and related prospectus and in accordance with the 2017 Plan and any applicable award agreement, and, where applicable, the consideration for the 2017 Plan Shares specified in the 2017 Plan and any applicable award agreement has been received by the Company, the 2017 Plan Shares will be validly issued, fully paid and nonassessable; and (b) the ESPP Shares have been issued and sold as contemplated in the Registration Statement and related prospectus and in accordance with the ESPP, and the consideration for the ESPP Shares specified in the ESPP has been received by the Company, the ESPP Shares will be validly issued, fully paid and nonassessable.

We do not express any opinion herein with respect to the laws of any jurisdiction other than, subject to the limitations and assumptions contained herein, the General Corporation Law of the State of Delaware.

This opinion speaks only as of the date the Registration Statement becomes effective under the Act, and we assume no obligation to revise or supplement this opinion thereafter. This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein.

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are within the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

---

| |
|:---|
| Very truly yours, |
| /s/ Faegre Drinker Biddle & Reath LLP |
| FAEGRE DRINKER BIDDLE & REATH LLP |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in the Registration Statement on Form S-8 pertaining to the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan and Celcuity Inc. 2017 Employee Stock Purchase Plan of our report dated March 31, 2025, with respect to the balance sheets of Celcuity Inc as of December 31, 2024 and 2023, and the related statements of operations, changes in stockholders' equity, and cash flows for each of the years ended December 31, 2024 and 2023 included in the Annual Report on Form 10-K of Celcuity Inc. for the year ended December 31, 2024, filed with the Securities and Exchange Commission.

/S/ Boulay PLLP

Minneapolis, Minnesota

June 4, 2025

## Ex-Filing

?xml version='1.0' encoding='ASCII'?

**Exhibit 107**

**Calculation of Filing Fee Tables**

**Form S-8**

(Form Type)

**Celcuity Inc.**

(Exact Name of Registrant as Specified in its Charter)

**Table 1: Newly Registered Securities**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title** | **Fee Calculation Rule** | **Amount Registered**<sup>(1)</sup>** | **Proposed Maximum Offering Price Per Unit**<sup>(2)</sup>** | **Maximum Aggregate Offering Price**<sup>(2)</sup>** | **Fee Rate** | **Amount of Registration Fee**<sup>(2)</sup>** |
| Equity | Common Stock, $0.001 par value per share, issuable under the Celcuity Inc. Amended and Restated 2017 Stock Incentive Plan | Rule 457(c) and <br>Rule 457(h) | 3371432 | $10.66 | $35939466 | 0.00015310 | $5503 |
| Equity | Common Stock, $0.001 par value per share, issuable under the Celcuity Inc. 2017 Employee Stock Purchase Plan | Rule 457(c) and <br>Rule 457(h) | 185716 | $10.66 | $1979733 | 0.00015310 | $304 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  |  | $37919199 |  | $5807 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  |  | – |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  |  | $5807 |

---

<sup>(1)</sup> The aggregate number of shares to be registered is subject to adjustment by reason of stock splits, stock dividends and other events pursuant to the anti-dilution provisions of the registrant's Amended and Restated 2017 Stock Incentive Plan and the registrant's 2017 Employee Stock Purchase Plan. Accordingly, pursuant to Rule 416, this registration statement covers, in addition to the number of shares of the registrant's Common Stock, $0.001 par value per share ("Common Stock"), shown in the table above, an indeterminate number of shares of Common Stock that may become issuable by reason of such provisions.

<sup>(2)</sup> Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) and Rule 457(h) of the Securities Act of 1933, as amended. The proposed maximum offering price per share is calculated on the basis of $10.66, the average of the high and low price of the registrant's Common Stock on May 30, 2025, as reported on The Nasdaq Capital Market, which is within five business days prior to filing this registration statement.